Theressa Wright

Adverse mortality effect of central sympathetic inhibition with sustained-release moxonidine in patients with heart failure (MOXCON)

European Journal of Heart Failure · 2003 · 267 citations

Drotrecogin alfa (activated) treatment in severe sepsis from the global open-label trial ENHANCE: further evidence for survival and safety and implications for early treatment

Critical Care Medicine · 2005 · 248 citations